Our Services
Medical Information
Helpful Resources
Published on: 9/12/2026
Recurring yeast infections (candidal balanitis) in men can be an early warning sign of uncontrolled diabetes, since excess sugar in urine and on the skin feeds Candida growth, and less often they may point to a weakened immune system from HIV or another condition. Other common causes include antibiotic use, obesity, poor hygiene under the foreskin, being uncircumcised, sex with a partner who has a yeast infection, and steroid or immunosuppressant medications. Warning signs that deserve prompt testing include repeat infections more than three times a year, plus symptoms like unusual thirst, frequent urination, unexplained weight loss, fatigue, night sweats, or swollen lymph nodes. Several factors determine whether your symptoms are routine or a red flag, and the details below explain which pattern points to diabetes, which suggests immune trouble, and when to see a doctor.
Because the same itching, redness, and discharge can come from a simple fungal overgrowth or from an undiagnosed metabolic or immune condition, guessing wrong can delay treatment that matters, so take a free, instant, online symptom check to see what your specific combination of symptoms suggests and get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/12/2026
Male yeast infections—often caused by the fungus Candida—can be uncomfortable and sometimes embarrassing. When these infections keep coming back, it’s natural to wonder whether they signal a more serious issue such as diabetes or HIV. Below, we’ll cover:
This information is based on credible medical sources. It’s meant to guide you, not replace professional advice. If you have serious or life-threatening concerns, speak to a doctor right away.
A male yeast infection (also called balanitis when it affects the head of the penis) occurs when Candida yeast—which lives on healthy skin—grows out of control. It can cause redness, itching, discharge and other discomforts.
Recognizing these signs early helps manage symptoms quickly and reduces the chance of complications.
Most uncomplicated infections clear up within 1–2 weeks of treatment. If symptoms persist beyond this or return frequently, further evaluation is needed.
Recurring yeast infections happen when the underlying conditions that allow Candida to multiply are not addressed. Common contributing factors include:
Two health conditions often raise concern:
Both can impair your body’s ability to keep yeast growth in check.
High blood sugar creates an ideal environment for yeast to thrive. Candia feeds on sugars, so elevated glucose in blood and tissues can lead to more frequent infections.
• Studies show that men with poorly controlled diabetes have a higher rate of candidal balanitis.
• Symptoms overlap with standard yeast infections, but you may notice:
– More severe or widespread rash
– Infections that don’t respond well to first-line treatment
If you have other diabetes warning signs—excessive thirst, frequent urination, unexplained weight loss—talk to your doctor about blood sugar testing.
HIV targets and weakens the immune system. As immunity declines, your body struggles to keep Candida and other microbes in balance.
Key points:
Recurring yeast infections alone don’t confirm HIV, but they can prompt a broader health evaluation.
If your male yeast infection keeps returning or won’t clear up, consider:
You can also do a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to get tailored guidance on what might be behind your symptoms, and what steps to take next.
Once you’ve treated an active infection and ruled out major health issues, these habits help prevent future flare-ups:
• Maintain clean, dry genitals
• Change underwear daily; choose cotton
• Avoid excessive sugar and refined carbs in your diet
• Limit antibiotic use to when absolutely necessary
• Get regular health screenings (diabetes, HIV, immune function)
Healthy lifestyle choices bolster your natural defenses against Candida.
Early evaluation ensures you address anything that could be life-threatening or serious. Your health matters—don’t hesitate to reach out for professional care.
(References)
* Dreizen S. Oral candidiasis. Am J Med. 1984 Oct 30;77(4D):28-33. PMID: 6496525.
* Pankhurst CL. Candidiasis (oropharyngeal). BMJ Clin Evid. 2009 Mar 18;2009. Epub 2009 Mar 18. PMID: 19445752; PMCID: PMC2907793.
* Pankhurst CL. Candidiasis (oropharyngeal). BMJ Clin Evid. 2012 Feb 20;2012. Epub 2012 Feb 20. PMID: 22348417; PMCID: PMC4429411.
* Awoyeni A, Olaniran O, Odetoyin B, Hassan-Olajokun R, Olopade B, Afolayan D, Adekunle O. Isolation and evaluation of Candida species and their association with CD4(+) T cells counts in HIV patients with diarrhoea. Afr Health Sci. 2017 Jun;17(2):322-329. doi: 10.4314/ahs.v17i2.5. PMID: 29062326; PMCID: PMC5637016.
* Spalanzani RN, Mattos K, Marques LI, Barros PFD, Pereira PIP, Paniago AMM, Mendes RP, Chang MR. Clinical and laboratorial features of oral candidiasis in HIV-positive patients. Rev Soc Bras Med Trop. 2018 May-Jun;51(3):352-356. doi: 10.1590/0037-8682-0241-2017. PMID: 29972567.
* Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022 Apr 13;74(Suppl_2):S162-S168. doi: 10.1093/cid/ciab1057. PMID: 35416967.
* Freitas VAQ, Santos AS, Zara ALSA, Costa CR, Godoy CSM, Soares RBA, Ataídes FS, Silva MDRR. Distribution and antifungal susceptibility profiles of Candida species isolated from people living with HIV/AIDS in a public hospital in Goiânia, GO, Brazil. Braz J Microbiol. 2023 Mar;54(1):125-133. doi: 10.1007/s42770-022-00851-w. Epub 2022 Nov 12. PMID: 36371517; PMCID: PMC9943819.
* Lu H, Hong T, Jiang Y, Whiteway M, Zhang S. Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies. Adv Drug Deliv Rev. 2023 Aug;199:114960. doi: 10.1016/j.addr.2023.114960. Epub 2023 Jun 10. PMID: 37307922.
* Tehrani S, Abbasian L, Dehghan Manshadi SA, Hasannezhad M, Ghaderkhani S, Keyvanfar A, Darvishi A, Aghdaee A. Vitamin D deficiency and oral candidiasis in patients with HIV infection: A case‒control study. BMC Infect Dis. 2024 Feb 19;24(1):217. doi: 10.1186/s12879-024-09065-x. Epub 2024 Feb 19. PMID: 38373939; PMCID: PMC10875808.
* Musinguzi B, Akampurira A, Derick H, Turyamuhika L, Mwesigwa A, Mwebesa E, Mwesigye V, Kabajulizi I, Sekulima T, Ocheng F, Itabangi H, Mboowa G, Sande OJ, Achan B. Extracellular hydrolytic enzyme activities and biofilm formation in Candida species isolated from people living with human immunodeficiency virus with oropharyngeal candidiasis at HIV/AIDS clinics in Uganda. Microb Pathog. 2025 Feb;199:107232. doi: 10.1016/j.micpath.2024.107232. Epub 2024 Dec 14. PMID: 39675440; PMCID: PMC11745906.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.